There are more chemotherapy methods for lymphoma, which need to be judged according to the actual condition of the patient and the type of the disease, such as chemotherapy using doxorubicin, bleomycin, vincristine and dacarbazine regimen. Lymphoma is divided into Hodgkin’s lymphoma and non-Hodgkin’s lymphoma, and its chemotherapy methods need to be judged according to the type of lymphoma and the progress of the patient’s disease, and cannot be generalized. For patients with typical Hodgkin’s lymphoma, if the condition is not serious, chemotherapy can be given with four drugs: doxorubicin, bleomycin, vincristine, and dacarbazine, which is clinically known as the ABVD regimen. For patients with refractory or recurrent Hodgkin’s lymphoma, they can be treated with the DHAP chemotherapy regimen of dexamethasone, cisplatin, and cytarabine, or the DICE chemotherapy regimen of dexamethasone, isocyclophosphamide, cisplatin, and pedunculated ethacridine. For patients with early-stage, predominantly nodular lymphocytic episodes of Hodgkin’s lymphoma, they can be treated with the above ABVD chemotherapy regimen, or they can choose to be treated with the CHOP chemotherapy regimen, which is composed of four drugs, namely, cyclophosphamide, adriamycin, vincristine, and prednisolone, as well as the CVP chemotherapy regimen, which is composed of three drugs, namely, cyclophosphamide, vincristine, and prednisolone. The above chemotherapy regimens are not only applicable to Hodgkin’s lymphoma, but also to non-Hodgkin’s lymphoma. However, due to the rapid progression of non-Hodgkin’s lymphoma and the difficulty in curing it, patients need to seek medical treatment as soon as possible and choose the appropriate treatment plan under the judgment of the doctor at the interview.
Support Us
Discussion
Share your experience, or seek help from fellow patients.
